Goldman Sachs
MGNX icon

Goldman Sachs’s MacroGenics MGNX Stock Holding History

Goldman Sachs’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-47,500
Closed -$1.47M – 7225
2015
Q4 		$1.47M Buy
+47,500
New +$1.44M ﹤0.01% 3919

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs's MGNX Position: Q1 2026 in Review

Goldman Sachs increased its MacroGenics (MGNX) stake by 51% in Q1 2026, buying an estimated $196K and bringing the position to 273,478 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #5266.

Goldman Sachs first reported a position in MGNX in Q3 2014 and has held it in 47 quarters since. The position peaked at $17.6M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Goldman Sachs held 273,478 shares of MacroGenics worth $790K as of Q1 2026.
  • Goldman Sachs bought 91,772 MacroGenics shares in Q1 2026, an estimated $196K.
  • MacroGenics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5266 holding.
  • Goldman Sachs first reported a position in MacroGenics in Q3 2014 and has held it in 47 quarters since.
  • Goldman Sachs's MacroGenics position peaked at $17.6M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.